Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 40 Neoplasms 8 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Quality of Life 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Hot Flashes 1 Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Gynecomastia 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Bone Density 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Tamoxifen 1 Fentanyl 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Quality of Life × Tamoxifen × Clear all

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

AstraZeneca

Phase 3 Completed

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡